Edgar Faber
- Hematology top 2%
- Genetics top 5%
- Oncology
- Molecular Biology
- Rheumatology top 10%
- Co-authors
- Karel IndrákDavid FriedeckýTomáš AdamLuděk RaidaMarie JarošováRichard PinkJ PazderaTomáš Papajík
- Topics
- Chronic Lymphocytic Leukemia Research (42 papers)Chronic Myeloid Leukemia Treatments (42 papers)Eosinophilic Disorders and Syndromes (23 papers)
- Cited by
- HematologyGeneticsPeriodontics
- Partner nations
- CzechiaFinlandUnited States
In The Last Decade
Edgar Faber
75 papers receiving 782 citations
Peers
Comparison fields: 5 of 99
- Hematology 401
- Genetics 289
- Oncology 168
- Molecular Biology 150
- Rheumatology 133
Countries citing papers authored by Edgar Faber
This map shows the geographic impact of Edgar Faber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Faber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Faber more than expected).
Fields of papers citing papers by Edgar Faber
This network shows the impact of papers produced by Edgar Faber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Faber. The network helps show where Edgar Faber may publish in the future.
Co-authorship network of co-authors of Edgar Faber
This figure shows the co-authorship network connecting the top 25 collaborators of Edgar Faber. A scholar is included among the top collaborators of Edgar Faber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar Faber. Edgar Faber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 8 | |
| 8 | 16 | |
| 9 | 21 | |
| 10 | 23 | |
| 11 | 12 | |
| 12 | 1 | |
| 13 | 10 | |
| 14 | 4 | |
| 15 | 38 | |
| 16 | 9 | |
| 17 | 9 | |
| 18 | 10 | |
| 19 | 3 | |
| 20 | 1 |
About Edgar Faber
Edgar Faber is a scholar working on Hematology, Genetics and Rheumatology, having authored 85 papers that have together received 814 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (42 papers), Chronic Myeloid Leukemia Treatments (42 papers) and Eosinophilic Disorders and Syndromes (23 papers). The work is most often cited by research in Hematology (401 citations), Genetics (289 citations) and Periodontics (52 citations). Edgar Faber has collaborated with scholars based in Czechia, Finland and United States. Frequent co-authors include Karel Indrák, David Friedecký, Tomáš Adam, Luděk Raida, Marie Jarošová, Richard Pink, J Pazdera, Tomáš Papajík, J Šimek and Peter Rohoň. Their work appears in journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.